ClinicalTrials.gg
CompletedNCT01048515Updated Jan 13, 2010

The Effect of Caffeine in Elderly Citizen Following Eight Hour Abstinence From Caffeine Containing Drinks & Foods

A Phase 4 interventional study of Caffeine in Healthy and Elderly, sponsored by Herning Hospital. Completed at 1 site in Denmark. Open to participants aged 70 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2010-01-13.

Sponsored by Herning Hospital · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
70 Years and older
Sex
All
01

Study summary

The study investigated the effect of caffeine on physical performance in healthy citizens aged over 70 years following eight hours of abstinence from caffeine containing drinks and foods. The main hypothesis was that 6 mg/kg caffeine would improve cycling endurance at 65% of expected maximal heart rate.

Read the detailed description

It is well documented that caffeine ingestion increases the endurance of young people exercising at 60%-85% of their maximal oxygen uptake (13;15;47). It also seems to improve endurance as measured by repeated sub-maximal isometric contraction (42), and decreases the rate of perceived exertion during exercise (6;9;46). Typically, doses of approximately 6 mg/kg caffeine were used in these studies.

With a growing number of elderly with a physical active lifestyle and many elderly participating in rehabilitation programs the endurance enhancing effect of caffeine is of increasing interest in this age group. We therefore conducted a study of healthy 75 year old citizens to investigate whether 6 mg/kg caffeine improved physical performance and reduced the perceived effort during work in healthy citizens aged ≥ 70 years. The main hypothesis was that caffeine would improve cycling endurance at 65% of expected maximal heart rate. The study showed that compared to placebo caffeine increased endurance by 25 % (p\<0.0001) and isometric sub-maximal strength with 54 % (p\<0.0001), reduced perceived exertion after 5 minutes of biking by 11 % (p=0.002), but in 21 of 30 participants there was reduced postural stability (with eyes open). In the above described study participants abstained from caffeine containing drinks and foods for 48 hours prior to each test. Half of the participants reported withdrawal symptoms. Such a long caffeine abstinence period would infer with daily life for many people. We therefore invited the participants from the above study to a repetition of the above study to test whether similar results would be obtained if participants only abstained from caffeine containing drinks and foods for 8 hours prior to each test.

02

Conditions studied

  • Healthy
  • Elderly

Keywords

  • Caffeine
  • Physiological Effects of Drugs
  • Central Nervous System Agents
03

In context

Lead sponsor

Herning Hospital is the lead sponsor of 21 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
70 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy elderly individuals aged over 70 years (Primarily those who previously have participated in an identical study with 48 hour caffeine abstinence)

Exclusion criteria

Exclusion Criteria:

  • Dementia or invalidating psychiatric disease
  • General debility, angina, or other diseases that would render participation in the test program impossible
  • Treatment with beta receptor blocking drugs, calcium-channel blocking drugs, digitalis, or nitroglycerine
  • Acute disease and injury
  • Diabetes
  • Conditions that would contraindicate caffeine ingestion or participation in the test program
  • Treatment with medication that interacts with caffeine
  • Ingestion of caffeine containing drinks and foods 8 hours before each session
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Caffeine

    Drug: Caffeine

  • Placebo comparator
    Placebo

    Drug: Caffeine

Interventions

  • Caffeine capsule 6 mg/kg given 1 hour before test

    Also known as: Identical looking placebo capsule given 1 hour before test

06

What researchers measure

Primary outcomes

  1. Endurance measured on an ergometer bicycle

    Time frame: The tests started 1 h following placebo/caffeine

Secondary outcomes

  1. Isometric endurance (arm flexion)

    Time frame: The tests started 1 h following placebo/caffeine

  2. Isometric maximum arm flexion strength

    Time frame: The tests started 1 h following placebo/caffeine

  3. Fatigue (Borg scale) during ergometer test

    Time frame: After 5 minutes biking and at exhaustion

  4. Postural stability

    Time frame: The tests started 1 h following placebo/caffeine

  5. Reaction time

    Time frame: The tests started 1 h following placebo/caffeine

  6. Walking speed

    Time frame: The tests started 1 h following placebo/caffeine

  7. Biochemistry: lactate, catecholamines, insulin, free fatty acids, glucose

    Time frame: Before intervention; before cycling; after 5 minutes of cycling; and at exhaustion

  8. Withdrawal symptoms

    Time frame: At the end of each test

  9. Side effects

    Time frame: At the end of each test

07

Study locations

1 site
  • Surgical Research Department
    Herning, Central Jutland 7400, Denmark
08

References and documents

Publications

  • Norager CB, Jensen MB, Madsen MR, Laurberg S. Caffeine improves endurance in 75-yr-old citizens: a randomized, double-blind, placebo-controlled, crossover study. J Appl Physiol (1985). 2005 Dec;99(6):2302-6. doi: 10.1152/japplphysiol.00309.2005. Epub 2005 Aug 4. PubMed 16081625 ↗
  • Norager CB, Jensen MB, Weimann A, Madsen MR. Metabolic effects of caffeine ingestion and physical work in 75-year old citizens. A randomized, double-blind, placebo-controlled, cross-over study. Clin Endocrinol (Oxf). 2006 Aug;65(2):223-8. doi: 10.1111/j.1365-2265.2006.02579.x. PubMed 16886964 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Feb 2005 and a primary completion of Nov 2005. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 12, 2010
First posted
Jan 13, 2010
Start
Feb 2005
Primary completionActual
Nov 2005
Last update
Jan 13, 2010
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 13, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01048515
Lead sponsor
Herning Hospital
First posted
Jan 13, 2010
Start date
Feb 2005
Primary completion
Nov 2005
Last update
Jan 13, 2010

Study contacts

Martin B Jensen, MD, Ph.d.
principal investigator · Surgical Research Unit, Department of Surgery P, Aarhus University Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Caffeine

Start the discussion